HOLXHOLOGIC INC

Nasdaq hologic.com


$ 75.02 $ 0.07 (0.09 %)    

Friday, 17-May-2024 15:59:59 EDT
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 75.02
$ 75.29
$ 0.00 x 0
$ 0.00 x 0
$ 74.16 - $ 75.29
$ 64.02 - $ 82.45
1,451,370
na
17.82B
$ 0.88
$ 38.20
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-30-2024 10-Q
2 02-02-2024 12-30-2023 10-Q
3 11-21-2023 09-30-2023 10-K
4 08-01-2023 07-01-2023 10-Q
5 05-02-2023 04-01-2023 10-Q
6 02-01-2023 12-31-2022 10-Q
7 11-15-2022 09-24-2022 10-K
8 07-27-2022 06-25-2022 10-Q
9 04-27-2022 03-26-2022 10-Q
10 02-02-2022 12-25-2021 10-Q
11 11-16-2021 09-25-2021 10-K
12 07-28-2021 06-26-2021 10-Q
13 04-28-2021 03-27-2021 10-Q
14 01-27-2021 12-26-2020 10-Q
15 11-17-2020 09-26-2020 10-K
16 07-29-2020 06-27-2020 10-Q
17 04-29-2020 03-28-2020 10-Q
18 01-29-2020 12-28-2019 10-Q
19 11-27-2019 09-28-2019 10-K
20 07-31-2019 06-29-2019 10-Q
21 05-01-2019 03-30-2019 10-Q
22 01-30-2019 12-29-2018 10-Q
23 11-20-2018 09-29-2018 10-K
24 07-31-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-08-2018 12-30-2017 10-Q
27 11-21-2017 09-30-2017 10-K
28 08-02-2017 07-01-2017 10-Q
29 05-10-2017 04-01-2017 10-Q
30 02-03-2017 12-31-2016 10-Q
31 11-17-2016 09-24-2016 10-K
32 07-27-2016 06-25-2016 10-Q
33 04-27-2016 03-26-2016 10-Q
34 01-27-2016 12-26-2015 10-Q
35 11-19-2015 09-26-2015 10-K
36 07-29-2015 06-27-2015 10-Q
37 04-30-2015 03-28-2015 10-Q
38 01-29-2015 12-27-2014 10-Q
39 11-20-2014 09-27-2014 10-K
40 07-31-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 argus-research-maintains-buy-on-hologic-raises-price-target-to-95

Argus Research analyst David Toung maintains Hologic (NASDAQ:HOLX) with a Buy and raises the price target from $89 to $95.

 jp-morgan-maintains-overweight-on-hologic-raises-price-target-to-91

JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $85 to $91.

 needham-reiterates-buy-on-hologic-maintains-90-price-target

Needham analyst Mike Matson reiterates Hologic (NASDAQ:HOLX) with a Buy and maintains $90 price target.

 hologic-q2-2024-adj-eps-103-beats-098-estimate-sales-1017b-beat-1002b-estimate

Hologic (NASDAQ:HOLX) reported quarterly Adj earnings of $1.03 per share which beat the analyst consensus estimate of $0.98 by ...

 needham-reiterates-buy-on-hologic-maintains-90-price-target

Needham analyst Mike Matson reiterates Hologic (NASDAQ:HOLX) with a Buy and maintains $90 price target.

 evercore-isi-group-maintains-in-line-on-hologic-raises-price-target-to-78

Evercore ISI Group analyst Vijay Kumar maintains Hologic (NASDAQ:HOLX) with a In-Line and raises the price target from $76 t...

 correction-citigroup-upgrades-hologic-to-buy-raises-price-target-to-95---rating-change-updated

CORRECTION: Citigroup analyst Patrick Donnelly upgrades Hologic (NASDAQ:HOLX) from Neutral to Buy and raises the price target f...

 citigroup-maintains-neutral-on-hologic-raises-price-target-to-95

Citigroup analyst Patrick Donnelly maintains Hologic (NASDAQ:HOLX) with a Neutral and raises the price target from $80 to $95.

 hologic-published-results-suggest-proportion-of-early-stage-hr-breast-cancer-survivors-may-be-over--or-undertreated-without-breast-cancer-index-genomic-testing

Results From a Large-Scale Prospective Study Investigating Long-Term Anti-Estrogen Therapy Recommendations Published in JNCCN —...

 first-lady-jill-biden-unveils-100m-in-federal-funding-to-support-rd---watch-out-for-these-women-health-stocks

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...

 ubs-maintains-neutral-on-hologic-raises-price-target-to-79

UBS analyst Elizabeth Garcia maintains Hologic (NASDAQ:HOLX) with a Neutral and raises the price target from $78 to $79.

 raymond-james-maintains-outperform-on-hologic-raises-price-target-to-88

Raymond James analyst Andrew Cooper maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $85 t...

 amazon-to-rally-over-41-here-are-10-top-analyst-forecasts-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 analyst-ratings-for-hologic
Analyst Ratings For Hologic
02/02/2024 12:00:27

 needham-maintains-buy-on-hologic-raises-price-target-to-90

Needham analyst Mike Matson maintains Hologic (NASDAQ:HOLX) with a Buy and raises the price target from $83 to $90.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION